RapidPulse Receives FDA Approval to Begin IDE Study in Ischemic Stroke Using Innovative Cyclic Aspiration System – Recently Completed Clinical Trial Shows Significantly Higher First Pass and Frontline Success Rates MIAMI, Dec. 11, 2024 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a Delaware corporation headquartered in Miami, Florida focused on improving the treatment success rate for acute ischemic stroke (AIS)...

Study Investigators Conclude RapidPulse™ Precise Cyclic Aspiration Is Highly Effective and Safe for Ischemic Stroke Large Vessel Occlusions Study Investigators Conclude RapidPulse™ Precise Cyclic Aspiration Is Highly Effective and Safe for Ischemic Stroke Large Vessel Occlusions

Atherectomy and Thrombectomy Devices Market Size To Hit US$ 6 billion By 2032, Owing To Increasing Investments in Healthcare Sector Globally | Persistence Market Research New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The atherectomy and thrombectomy devices market is expected to escalate at a CAGR of 5.7%, from US$ 3.5 billion in 2022 to US$ 6 billion through 2032.  ...

RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy MIAMI, June 23, 2021 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, today announced the closing of a $15...